https://touchoncology.com/insight/whats-next-for-cns-tumours/?_rt=MTN8MXxlYXV8MTc4ODgyNjk0Nw&_rt_nonce=db8b432fc2
ANA 2025: Emerging immunotherapies in neuro-oncology – what’s next for CNS tumours? - touchONCOLOGY
Dr Rimas Lukas highlights early-stage neuro-oncology research presented at ANA 2025. Key approaches targeting CNS tumours include immune checkpoint inhibition,...
cns tumoursanaemergingimmunotherapiesneuro
https://www.frontiersin.org/journals/medicine/articles/10.3389/fmed.2022.1070828/full
Frontiers | Case report: BRAF-inhibitor therapy in BRAF-mutated primary CNS tumours including one...
BRAF V600E oncogene mutations have been reported in multiple central nervous system (CNS) tumour types, and emerging evidence supports the use of targeted th...
case reportbraf inhibitorcns tumoursfrontierstherapy
https://acnr.co.uk/articles/classification-of-paediatric-tumours/
The 2016 WHO Classification of paediatric CNS tumours – the essentials | ACNR
Jan 7, 2025 - The 2016 WHO Classificationof paediatric CNS tumours –the essentials
cns tumoursclassificationpaediatricessentials